Skip to content

Comparison of Pain Therapeutic Effects After Benign Mastectomy

Clinical Comparison of Postoperative Pain Therapeutic Effects After Benign Mastectomy

Status
Completed
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00519246
Acronym
COPTEAM
Enrollment
2000
Registered
2007-08-22
Start date
2007-02-28
Completion date
2007-12-31
Last updated
2009-03-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Mastectomy, Pain, Postoperative

Keywords

Breast Neoplasms, Non-Steroidal Anti-Inflammatory Agents, Analgesia

Brief summary

With the incremental trend of benign breast tumor, the surgical process of mastectomy was proceeded too much every day, especially in the Maternal Health Care Hospital, but whether the investigators can find another way to relieve the postoperative pain after such an operation is still unknown. The investigators hypothesized that the pain from the relatively small surgery may not be significant compared to different treatments, even if no drug was delivered to them. The investigators are enrolling patients who underwent mastectomy from benign breast tumor, and are observing the analgesic effects of different drugs.

Interventions

DRUGSaline

Saline 5 ml administrated intravenously

DRUGOpioid

Butorphanol tartrate 1 mg i.v.

DRUGNSAID

Flurbiprofen Axetil 50 mg i.v.

Sponsors

Nanjing Medical University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 64 Years
Healthy volunteers
No

Inclusion criteria

* Chinese * No cardiac and pulmonary diseases * ASA I-II * No alcohol drinking.

Exclusion criteria

* \<19yrs, and \>65yrs * History of central active drugs administration * Drug abuse * Hypertension * Diabetes * Any other chronic diseases.

Design outcomes

Primary

MeasureTime frame
Visual analog scale (VAS) rating of pain0-24h after surgeries

Secondary

MeasureTime frame
VAS rating of sedation0h to 24h after the end of the operation
Overall VAS rating of satisfaction with analgesia24 h after operation
Incidence of side effectsFrom the initiation of analgesia (0 h) to the end of the study (24 h postoperative)

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026